ABCL
AbCellera Soars Ahead with Record-Breaking Q1 2026 Earnings
AbCellera, a leading biotech company, has just released its first-quarter earnings for 2026, showcasing impressive growth and milestones achieved. In an investor relations call on May 11th, the company's top executives outlined their vision for the year ahead. The presentation was led by Dr. Carl Hansen, President and